Ischemia-modified albumin levels in patients with acute decompensated heart failure treated with dobutamine or levosimendan: IMA-HF study

OBJECTIVE: Ischemia-modified albumin (IMA) is a sensitive biomarker of myocardial ischemia. However, data on IMA levels in acute heart failure (HF) are still lacking. In this study, we aimed to evaluate serum IMA levels in acute decompensated HF and the effects of dobutamine and levosimendan treatme...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Anatol J Cardiol
Main Authors: Çavuşoğlu, Yüksel, Korkmaz, Şule, Demirtaş, Selda, Gencer, Erkan, Şaşmaz, Hatice, Mutlu, Fezan, Güneş, Hakan, Mert, Uğur Kadir, Özdemir, Sedat, Kalaycı, Süleyman, Yılmaz, Mehmet Birhan
Formato: Artigo
Idioma:Inglês
Publicado em: Kare Publishing 2016
Assuntos:
Original Investigation
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5336859/
https://ncbi.nlm.nih.gov/pubmed/26301344
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5152/akd.2015.6156
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados